Presenting Companies Represent
Transformative Technologies from the Rocky Mountain
West
DENVER, July 31,
2024 /PRNewswire/ -- Colorado BioScience Association
(CBSA) highlights the momentum and opportunities in Colorado's life sciences community and the
greater Rocky Mountain region at the 2024 Rocky Mountain Life
Sciences Investor & Partnering Conference in Breckenridge, Colorado, on September 12 and 13.
The conference aims to drive more commercialization and patient
impact by attracting new funding and strategic partnerships in a
region recognized as a leading hub for health innovation. CNBC
covered record fundraising by Colorado's life sciences ecosystem earlier
this year. In the first six months of 2024, life sciences companies
and organizations raised more than $1.2
billion. Additionally, Colorado Hub for Health Impact, a
national economic development campaign led by a collaboration of 22
partners, is attracting new life sciences companies, talent, and
investors to Colorado.
Known for its exclusive focus on life sciences, the conference
will feature more than 30 pre-selected startup, emerging, and
growth companies. Presenting companies are
developing transformative devices, diagnostics and therapies.
They are tackling cancers, drug-resistant diseases, autoimmune
conditions, and women's health disparities using some of the most
promising technological advancements in artificial intelligence,
regenerative and personalized medicine, and synthetic
biology.
"Colorado BioScience Association encourages investors and
strategic partners to join us at the 2024 Rocky Mountain Life
Sciences Investor & Partnering Conference and seize
opportunities to invest in and partner with pioneering Colorado life sciences companies," said
Elyse Blazevich, Colorado BioScience Association President
& CEO. "They represent the breadth of cutting-edge research and
innovation in the Rocky Mountain West, solving some of the most
pressing and pervasive challenges in healthcare."
2024 Presenting Companies: Rocky Mountain Life Sciences
Investor & Partnering Conference
Biotech +
Pharma
|
Raising Up to
$10M
Emet
Surgical
Illumen Therapeutics,
Inc.
Onconaut Therapeutics
Inc.
MyUTI, Inc.
NowVitals
PFRx, LLC
Photon
Pharma
Reglagene
RheumaGen
SiVEC Biotechnologies,
Inc.
|
Raising $10M+
Ajna BioSciences
PBC
Arpeggio Bio
Codebreaker
Tx
Elysium
Therapeutics
NuvOx Therapeutics
Inc.
STAQ Pharma
Think
Bioscience
Trampoline Pharma,
Inc.
Vona
Oncology
|
Medtech
|
Raising Up to
$10M
Aspero
Medical
EnteroTrack
LLC
Eye to Eye
Telehealth
Green Sun
Medical
illumifyDx,
Inc.
Lazzaro Medical,
Inc.
TissueForm
Vega Surgical
Systems
|
Raising $10M+
AOA Dx
Burst
Diagnostics
Darwin
Biosciences
GelSana Therapeutics,
Inc.
|
New for 2024, later-stage companies with significant track
records of success in Colorado,
including Biodesix, Enveda Biosciences, OnKure Therapeutics, and
Umoja Biopharma, will share their stories. Additionally, leaders
from the state's academic and research institutions will highlight
some of their emerging transformative research that is attracting
large federal grant funding.
"The conference connects high-profile investors and the most
promising companies in the Rocky Mountain region," said
Emily Martini, Colorado BioScience
Association Vice President, Partnerships. "We chose the location
and time of year to offer guests a classic Colorado experience—build connections in a
relaxed mountain setting during the fall color season and
Breckenridge's iconic
Oktoberfest."
The conference, to be held at the Beaver Run Resort &
Conference Center in Breckenridge,
connects companies with high-profile investors and strategic
partners from across the United
States through pitch presentations and networking in a
beautiful mountain location. Siri
Lindley, world champion triathlete, business performance
coach, and one of Tony Robbins' top
motivational speakers, who credits a clinical trial at the
University of Colorado Anschutz Medical
Campus for saving her life, will inspire attendees during her
opening keynote remarks. A panel of high-profile investors and
strategic partners will provide insights on emerging investing
trends and areas of interest to kick off the second day.
Due to standing room only turnout at the 2022 event, investors
and strategic partners are encouraged to register early.
About Colorado BioScience Association
Colorado BioScience Association (CBSA) creates co-opportunity
for the Colorado life sciences
community. CBSA champions a collaborative life sciences ecosystem
and advocates for a supportive business climate. From concept to
commercialization, member companies and organizations drive global
health innovations, products, and services that improve and save
lives. The association leads Capital and Growth, Education and
Networking, Policy and Advocacy, and Workforce Cultivation to make
its members stronger together. Learn more at cobioscience.com.
Media Contact
Sheliah
Reynolds
Primavera Group for Colorado BioScience Association
(720) 289-4739
sheliah@theprimaveragroup.com
Investor Relations Contact
Tiberend Strategic
Advisors, Inc.
David Irish
(231) 632-0002
dirish@tiberend.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/colorado-bioscience-association-highlights-investment-opportunities-at-the-2024-rocky-mountain-life-sciences-investor--partnering-conference-302210509.html
SOURCE Colorado BioScience Association